| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Ramtin Agah is Chief Medical Officer at RNXT. From August 2021 to January 2026, the filings on record show 13 open-market purchases and 0 sales. Ramtin Agah's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.0M at current prices.
Historically, Ramtin Agah's trades have earned a strong insider score of 75/100 across 14 rated trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +9.7%.
Net of sales, the RNXT filings show accumulation of 222,165 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2025 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 26,000 | $0.84 | $21,840.00 | +2.5% | +65.0% | +17.4% | |
| Jan 26, 2024 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 40,983 | $0.00 | - | +632.7% | +15.2% | +31.4% | |
| Jun 7, 2022 | RNXT Renovorx, Inc. | Chief Medical Officer | Buy | 5,182 | $1.93 | $10,001.26 | +400.2% | +18.5% | +1.5% |